Stratos Wealth Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Stratos Wealth Advisors's ELV Position: Q1 2026 in Review
Stratos Wealth Advisors reduced its Elevance Health (ELV) stake by 39% in Q1 2026, selling an estimated $158K and leaving 740 shares worth $217K. The position accounts for 0.01% of the portfolio, ranked #568.
Stratos Wealth Advisors first reported a position in ELV in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.47M in Q4 2022. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Stratos Wealth Advisors held 740 shares of Elevance Health worth $217K as of Q1 2026.
- Stratos Wealth Advisors sold 482 Elevance Health shares in Q1 2026, an estimated $158K.
- Elevance Health made up 0.01% of Stratos Wealth Advisors's portfolio in Q1 2026, its #568 holding.
- Stratos Wealth Advisors first reported a position in Elevance Health in Q4 2021 and has held it in 16 quarters since.
- Stratos Wealth Advisors's Elevance Health position peaked at $1.47M in Q4 2022.
- 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Stratos Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.